Grapheal

The unique Sensfit sensor technology makes use of high electrical conductivity and extreme flexibility of graphene in human health monitoring. Innovative smart sensors coupled with cutting edge artificial intelligence providing insights to transform lives. Building on two decades of sensor tech and graphene research, Sensfit uses an innovative architectural design of overlaid smart sensors with graphene ink to provide a highly adaptive sensor platform able to analyse real time data on force, pressure, physical movement, activity, balance, gait and its pathologies. The technology utilises an innovative, scalable design of graphene integrated smart sensors along with in-built hardware and software, enabling monitoring of human bodily conditions. Building on two decades of sensor tech and graphene research, Sensfit uses an innovative architectural design of overlaid smart sensors with graphene to provide a highly adaptive sensor platform.

Grapheton’s main products are next generation carbon-based implantable devices with integrated on-chip self-powering energy sources. Equally importantly, Grapheton’s probes can simultaneously read both the electrical and chemical signals that regulate processes throughout the body. Grapheton continues to build a rich portfolio of forward-looking solutions, proprietary technologies, and intellectual property in these cutting-edge areas. Bioelectronics, the treatment of disease, injury and disability using electronic devices, is a huge and growing market. A much more natural fit with biological processes, our products are made of a homogenous non-granular carbon material that could stay implanted in the human body for several decades without degradation or damage to the underlying tissues. The sensitivity and selectivity of Grapheton’s probes exceed state-of-the-art as supported by peer-reviewed scientific publications. Over the past fifteen years, the underlying technology of Grapheton was developed at and licensed from NanoFAB.SDSU, which is part of the Center for Neurotechnology (CNT) Engineering Research Center, a collaboration between University of Washington, MIT and San Diego State University. As our technology comes out of the laboratory environment and enters clinical applications, Grapheton’s technology has the potential to revolutionize human bioelectronic implants by creating lifelong treatments that continuously adjust through closed-loop monitoring of the body’s electrical and chemical environment.

We are currently using machine learning to give our chip the ability to detect useful scent profiles. Using this principle we are able to determine the concentration of the target gas with. We are a global leader in utilising the properties of Graphene in the commercial sensor space. Founded in 2018 in Bristol Robotics Laboratory, where the company is based. This innovative technology holds the potential to transform various sectors, including food storage, ‘health wearables’, and environmental management. By providing precise and timely data, AC’s technology can facilitate informed decision-making, leading to enhanced operational efficiency and sustainability. We then use Ai to give our sensor the ability to focus on specific target scents, such as food degrading. This makes us one of the leading companies in the world with commercially viable graphene sensors.

We are a team of highly experienced materials and neurotech believers, backed by leading tech and scientific advisors. They are the leading cause of disability and the 2nd cause of mortality worldwide. Graphene enables a novel class of flexible, high-resolution, high-precision graphene-based implantable neurotechnology, delivering increasing treatment efficiency.

We are a San Diego based start-up specializing in the design and fabrication of eco-friendly, biocompatible, wearable sensing technologies. Our mission is to advance remote health monitoring applications using environmentally sustainable materials and processes.

We are a team of highly experienced materials and neurotech believers, backed by leading tech and scientific advisors. They are the leading cause of disability and the 2nd cause of mortality worldwide. Graphene enables a novel class of flexible, high-resolution, high-precision graphene-based implantable neurotechnology, delivering increasing treatment efficiency.